$82.47
0.03[0.04%]
Last update: 2:05PM Get Real Time Here
Biomarin Pharmaceutical
(NASDAQ:BMRN)Biomarin Pharmaceutical Stock (NASDAQ:BMRN), Quotes and News Summary
Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
| Open | $83.200 |
| Close | - |
| Volume / Avg. | 367.478K / 1.566M |
| Day Range | 81.990 - 83.585 |
| 52 Wk Range | 76.020 - 99.560 |
| Market Cap | $15.659B |
| P/E Ratio | 77.774 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 0 |
| Short Interest | 1.63% |
| Days to Cover | 2.74 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biomarin Pharmaceutical (BMRN) stock?
You can purchase shares of Biomarin Pharmaceutical (NASDAQ: BMRN) through any online brokerage.
Who are Biomarin Pharmaceutical's (BMRN) competitors?
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Biomarin Pharmaceutical (BMRN) stock?
The latest price target for Biomarin Pharmaceutical (NASDAQ: BMRN) was reported by Morgan Stanley on Friday, April 26, 2024. The analyst firm set a price target for 112.00 expecting BMRN to rise to within 12 months (a possible 35.81% upside). 42 analyst firms have reported ratings in the last year.
Current Stock Price for Biomarin Pharmaceutical (BMRN)?
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $82.47 last updated Today at May 6, 2024 at 2:05 PM EDT.
Does Biomarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for Biomarin Pharmaceutical.
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical’s Q2 earnings are confirmed for Monday, July 29, 2024.
Is Biomarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for Biomarin Pharmaceutical.
What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.